These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3491096)

  • 1. PET, CT, and MR imaging in cerebrovascular disease.
    Heiss WD; Herholz K; Böcher-Schwarz HG; Pawlik G; Wienhard K; Steinbrich W; Friedmann G
    J Comput Assist Tomogr; 1986; 10(6):903-11. PubMed ID: 3491096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [MR of ischemic brain diseases. A comparison with CT, PET (18-fluorodeoxyglucose) and angiographic results].
    Steinbrich W; Friedmann G; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Rofo; 1986 Aug; 145(2):173-81. PubMed ID: 3018855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
    González RG; Fischman AJ; Guimaraes AR; Carr CA; Stern CE; Halpern EF; Growdon JH; Rosen BR
    AJNR Am J Neuroradiol; 1995 Oct; 16(9):1763-70. PubMed ID: 8693972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in diagnosing brainstem vascular lesions that cause abnormal eye movements.
    Kiyosawa M; Ishii K; Inoue C; Kawasaki T; Senda M
    Am J Ophthalmol; 1996 Oct; 122(4):557-67. PubMed ID: 8862054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis of cerebrovascular disorders using nuclear magnetic resonance tomography].
    Wimberger D; Kramer J; Prayer L; Stiglbauer R; Imhof H
    Acta Med Austriaca; 1991; 18(2):29-34. PubMed ID: 1887732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of regional brain blood flow and glucose metabolism in focal cerebrovascular disease measured by dynamic positron emission tomography of fluorine-18-labelled tracers.
    Beil C
    J Neurol; 1987 Jun; 234(5):315-21. PubMed ID: 3497233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular disease: use of fluorodeoxyglucose.
    Herholz K; Heiss WD
    Semin Neurol; 1989 Dec; 9(4):293-300. PubMed ID: 2701775
    [No Abstract]   [Full Text] [Related]  

  • 9. Positron emission tomography.
    Cohen RM; Semple WE; Gross M
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic derangement in viable periinfarct tissue in the course of acute ischaemic infarction: a multitracer positron emission tomography (PET) study.
    Huber M; Fink GR; Herholz K; Heiss WD
    Neurol Res; 1992; 14(2 Suppl):184-6. PubMed ID: 1355884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive measurement of blood flow, oxygen consumption, and glucose utilization in the same brain regions in man by positron emission tomography: concise communication.
    Baron JC; Lebrun-Grandie P; Collard P; Crouzel C; Mestelan G; Bousser MG
    J Nucl Med; 1982 May; 23(5):391-9. PubMed ID: 6978932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of positron emission tomography in cerebrovascular disease.
    Powers WJ; Zazulia AR
    Neuroimaging Clin N Am; 2003 Nov; 13(4):741-58. PubMed ID: 15024958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of cerebral blood flow and metabolism.
    Coles JP
    Curr Opin Anaesthesiol; 2006 Oct; 19(5):473-80. PubMed ID: 16960477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of cerebrovascular diseases utilizing NMR imaging].
    Kato H; Tobita M; Kogure K
    No To Shinkei; 1985 May; 37(5):459-68. PubMed ID: 3896275
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography study of regional glucose metabolism in cerebral ischemia--topographic and kinetic aspects.
    Pawlik G; Wienhard K; Herholz K; Wagner R; Heiss WD
    Prog Brain Res; 1984; 62():253-62. PubMed ID: 6335919
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic imaging in hemianopsia using positron emission tomography with 18F-deoxyfluoroglucose.
    Kiyosawa M; Mizuno K; Hatazawa J; Fukuda H; Yamada K; Ito M; Matsuzawa T; Watanuki S; Ido T
    Am J Ophthalmol; 1986 Mar; 101(3):310-9. PubMed ID: 3485381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 19. Determination of regional cerebral blood flow in patients with cerebral infarction. Use of fluoromethane labeled with fluorine 18 and positron emission tomography.
    Celesia GG; Polcyn RE; Holden JE; Nickles RJ; Koeppe RA; Gatley SJ
    Arch Neurol; 1984 Mar; 41(3):262-7. PubMed ID: 6607723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional brain study by radionuclide neuroimaging].
    Uemura K
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.